Heartland Group Holdings (HGH) Stock Overview
Provides various financial services in New Zealand and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
HGH Community Fair Values
See what 35 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Heartland Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$1.25 |
| 52 Week High | NZ$1.30 |
| 52 Week Low | NZ$0.79 |
| Beta | 0.76 |
| 1 Month Change | 1.22% |
| 3 Month Change | 9.21% |
| 1 Year Change | 53.70% |
| 3 Year Change | -29.66% |
| 5 Year Change | -42.36% |
| Change since IPO | 44.77% |
Recent News & Updates
HGH: Updated Fair Value Highlights Sensitivity To Margins And P E Assumptions
Analysts have increased their fair value estimate for Heartland Group Holdings from NZ$0.85 to NZ$1.17, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples as the main factors behind the higher price target. Analyst Commentary on Heartland Group Holdings While the higher fair value estimate gives a more constructive anchor for Heartland Group Holdings, some of the detail behind analyst thinking points to risks that readers should keep in mind, particularly around the assumptions used for growth, margins and future valuation multiples.HGH: Higher Margin Assumptions Will Support Stronger Earnings Conversion Outlook
The analyst price target for Heartland Group Holdings has been revised to NZ$1.40 from NZ$1.15, with analysts pointing to adjusted assumptions around the discount rate, revenue growth, profit margin and future P/E to support the change. Analyst Commentary Recent price target changes for Heartland Group Holdings reflect a more constructive tone from bullish analysts, who are reassessing valuation assumptions around discount rates, revenue growth, profit margins and future P/E multiples.HGH: Higher Margin Assumptions Will Shape Future Return Potential
Analysts have lifted the Heartland Group Holdings price target from NZ$1.03 to NZ$1.29, reflecting updated assumptions that include a higher fair value estimate, a slightly lower discount rate, more moderate revenue growth, stronger profit margins, and a modestly lower future P/E. Analyst Commentary Analysts covering Heartland Group Holdings have framed the higher price target as a recalibration of valuation inputs rather than a wholesale change in the outlook, with a focus on how the company might execute against its revenue, margin and capital allocation plans.Recent updates
Shareholder Returns
| HGH | NZ Banks | NZ Market | |
|---|---|---|---|
| 7D | 1.2% | 1.2% | -0.6% |
| 1Y | 53.7% | 8.2% | 5.4% |
Return vs Industry: HGH exceeded the NZ Banks industry which returned 8.2% over the past year.
Return vs Market: HGH exceeded the NZ Market which returned 5.4% over the past year.
Price Volatility
| HGH volatility | |
|---|---|
| HGH Average Weekly Movement | 4.8% |
| Banks Industry Average Movement | 3.1% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in NZ Market | 8.3% |
| 10% least volatile stocks in NZ Market | 2.8% |
Stable Share Price: HGH has not had significant price volatility in the past 3 months compared to the NZ market.
Volatility Over Time: HGH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1875 | n/a | Andrew Dixson | www.heartlandgroup.info |
Heartland Group Holdings Limited, together with its subsidiaries, provides various financial services in New Zealand and Australia. It operates through Motor, Reverse Mortgages, Personal Lending, Business, Rural, Australian Banking Group, and Other segments. The company offers motor vehicle finance; reverse mortgage lending; and transactional, home loans, and personal loans to individuals.
Heartland Group Holdings Limited Fundamentals Summary
| HGH fundamental statistics | |
|---|---|
| Market cap | NZ$1.18b |
| Earnings (TTM) | NZ$84.05m |
| Revenue (TTM) | NZ$308.70m |
Is HGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HGH income statement (TTM) | |
|---|---|
| Revenue | NZ$308.70m |
| Cost of Revenue | NZ$0 |
| Gross Profit | NZ$308.70m |
| Other Expenses | NZ$224.66m |
| Earnings | NZ$84.05m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 19, 2026
| Earnings per share (EPS) | 0.089 |
| Gross Margin | 100.00% |
| Net Profit Margin | 27.23% |
| Debt/Equity Ratio | 44.6% |
How did HGH perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/04 16:31 |
| End of Day Share Price | 2026/08/04 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Heartland Group Holdings Limited is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wade Gardiner | Deutsche Bank |
| Benjamin Crozier | Forsyth Barr Group Ltd. |
| Grant Lowe | Jarden Limited |